Trial Profile
Comparison of Efficacy of Liraglutide, Metformin and Gliclazide MR on Hepatic Lipid Content in Patients With Type 2 Diabetes (T2DM) and Non-alcoholic Fatty Liver (NAFLD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Gliclazide (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association
- 03 Mar 2017 New trial record